APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ambulatory Polysomnography (Psg) System

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ambulatory Polysomnography (Psg) System Market Analysis and Forecast 2026-2032

22 January 2026192 pages

Choose your research edition.

Industry ResearchAmbulatory Polysomnography (Psg) System Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Ambulatory Polysomnography (Psg) System Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Ambulatory Polysomnography (Psg) System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ambulatory Polysomnography (Psg) System Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ambulatory Polysomnography (Psg) System Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Ambulatory Polysomnography (Psg) System market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Ambulatory Polysomnography (Psg) System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ambulatory Polysomnography (Psg) System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ambulatory Polysomnography (Psg) System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ambulatory Polysomnography (Psg) System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Ambulatory Polysomnography (Psg) System include Natus Embla, Compumedics, Neurosoft, Cadwell Industries, Philips, Löwenstein Medical, Nihon Kohden, Nox Medical and Somnomedics AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Ambulatory Polysomnography (Psg) System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ambulatory Polysomnography (Psg) System, also provides the revenue of main regions and countries. Of the upcoming market potential for Ambulatory Polysomnography (Psg) System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ambulatory Polysomnography (Psg) System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ambulatory Polysomnography (Psg) System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Ambulatory Polysomnography (Psg) System revenue, projected growth trends, production technology, application and end-user industry.

Ambulatory Polysomnography (Psg) System Segment by Company

Natus Embla

Compumedics

Neurosoft

Cadwell Industries

Philips

Löwenstein Medical

Nihon Kohden

Nox Medical

Somnomedics AG

Advanced Brain Monitoring (ABM)

DEYMED Diagnostic

Hangzhou NeuroTrace

Beijing BMC Medical

Hunan VentMed Medical Technology

Hangzhou Lucky Day Medical Technology

Ambulatory Polysomnography (Psg) System Segment by Type

＜10-Channel

≥10-Channel

Ambulatory Polysomnography (Psg) System Segment by Application

Hospital

Home

Others

Ambulatory Polysomnography (Psg) System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambulatory Polysomnography (Psg) System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ambulatory Polysomnography (Psg) System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambulatory Polysomnography (Psg) System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Ambulatory Polysomnography (Psg) System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Ambulatory Polysomnography (Psg) System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ambulatory Polysomnography (Psg) System revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ambulatory Polysomnography (Psg) System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ＜10-Channel Major Player Table 3. ≥10-Channel Major Player Table 4. Global Ambulatory Polysomnography (Psg) System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Home Major Player Table 7. Others Major Player Table 8. Ambulatory Polysomnography (Psg) System Industry Trends Table 9. Ambulatory Polysomnography (Psg) System Industry Drivers Table 10. Ambulatory Polysomnography (Psg) System Industry Opportunities and Challenges Table 11. Ambulatory Polysomnography (Psg) System Industry Restraints Table 12. Global Ambulatory Polysomnography (Psg) System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Ambulatory Polysomnography (Psg) System Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Ambulatory Polysomnography (Psg) System Market Share by Region (2021-2026) Table 15. Global Ambulatory Polysomnography (Psg) System Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Ambulatory Polysomnography (Psg) System Market Share by Region (2027-2032) Table 17. Global Ambulatory Polysomnography (Psg) System Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Players (2021-2026) Table 19. Global Ambulatory Polysomnography (Psg) System Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Ambulatory Polysomnography (Psg) System Key Players Headquarters & Area Served Table 21. Global Ambulatory Polysomnography (Psg) System Players, Product Type & Application Table 22. Global Ambulatory Polysomnography (Psg) System Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Ambulatory Polysomnography (Psg) System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Ambulatory Polysomnography (Psg) System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Ambulatory Polysomnography (Psg) System Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Type (2021-2026) Table 29. Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Type (2027-2032) Table 30. Global Ambulatory Polysomnography (Psg) System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Ambulatory Polysomnography (Psg) System Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Application (2021-2026) Table 34. Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Application (2027-2032) Table 35. Natus Embla Company Information Table 36. Natus Embla Business Overview Table 37. Natus Embla Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Natus Embla Ambulatory Polysomnography (Psg) System Product Portfolio Table 39. Natus Embla Recent Development Table 40. Compumedics Company Information Table 41. Compumedics Business Overview Table 42. Compumedics Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Compumedics Ambulatory Polysomnography (Psg) System Product Portfolio Table 44. Compumedics Recent Development Table 45. Neurosoft Company Information Table 46. Neurosoft Business Overview Table 47. Neurosoft Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Neurosoft Ambulatory Polysomnography (Psg) System Product Portfolio Table 49. Neurosoft Recent Development Table 50. Cadwell Industries Company Information Table 51. Cadwell Industries Business Overview Table 52. Cadwell Industries Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Cadwell Industries Ambulatory Polysomnography (Psg) System Product Portfolio Table 54. Cadwell Industries Recent Development Table 55. Philips Company Information Table 56. Philips Business Overview Table 57. Philips Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Philips Ambulatory Polysomnography (Psg) System Product Portfolio Table 59. Philips Recent Development Table 60. Löwenstein Medical Company Information Table 61. Löwenstein Medical Business Overview Table 62. Löwenstein Medical Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Löwenstein Medical Ambulatory Polysomnography (Psg) System Product Portfolio Table 64. Löwenstein Medical Recent Development Table 65. Nihon Kohden Company Information Table 66. Nihon Kohden Business Overview Table 67. Nihon Kohden Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Nihon Kohden Ambulatory Polysomnography (Psg) System Product Portfolio Table 69. Nihon Kohden Recent Development Table 70. Nox Medical Company Information Table 71. Nox Medical Business Overview Table 72. Nox Medical Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Nox Medical Ambulatory Polysomnography (Psg) System Product Portfolio Table 74. Nox Medical Recent Development Table 75. Somnomedics AG Company Information Table 76. Somnomedics AG Business Overview Table 77. Somnomedics AG Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Somnomedics AG Ambulatory Polysomnography (Psg) System Product Portfolio Table 79. Somnomedics AG Recent Development Table 80. Advanced Brain Monitoring (ABM) Company Information Table 81. Advanced Brain Monitoring (ABM) Business Overview Table 82. Advanced Brain Monitoring (ABM) Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Advanced Brain Monitoring (ABM) Ambulatory Polysomnography (Psg) System Product Portfolio Table 84. Advanced Brain Monitoring (ABM) Recent Development Table 85. DEYMED Diagnostic Company Information Table 86. DEYMED Diagnostic Business Overview Table 87. DEYMED Diagnostic Ambulatory Polysomnography (Psg) System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. DEYMED Diagnostic Ambulatory Polysomnography (Psg) System Product Portfolio Table 89. DEYMED Diagnostic Recent Development Table 90. Hangzhou NeuroTrace Company Information Table 91. Hangzhou NeuroTrace Business Overview Table 92. Hangzhou NeuroTrace Ambulatory Polysomnography (Psg) System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Hangzhou NeuroTrace Ambulatory Polysomnography (Psg) System Product Portfolio Table 94. Hangzhou NeuroTrace Recent Development Table 95. Beijing BMC Medical Company Information Table 96. Beijing BMC Medical Business Overview Table 97. Beijing BMC Medical Ambulatory Polysomnography (Psg) System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Beijing BMC Medical Ambulatory Polysomnography (Psg) System Product Portfolio Table 99. Beijing BMC Medical Recent Development Table 100. Hunan VentMed Medical Technology Company Information Table 101. Hunan VentMed Medical Technology Business Overview Table 102. Hunan VentMed Medical Technology Ambulatory Polysomnography (Psg) System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Hunan VentMed Medical Technology Ambulatory Polysomnography (Psg) System Product Portfolio Table 104. Hunan VentMed Medical Technology Recent Development Table 105. Hangzhou Lucky Day Medical Technology Company Information Table 106. Hangzhou Lucky Day Medical Technology Business Overview Table 107. Hangzhou Lucky Day Medical Technology Ambulatory Polysomnography (Psg) System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Hangzhou Lucky Day Medical Technology Ambulatory Polysomnography (Psg) System Product Portfolio Table 109. Hangzhou Lucky Day Medical Technology Recent Development Table 110. North America Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2026) & (US$ Million) Table 111. North America Ambulatory Polysomnography (Psg) System Revenue by Type (2027-2032) & (US$ Million) Table 112. North America Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Ambulatory Polysomnography (Psg) System Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Ambulatory Polysomnography (Psg) System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Ambulatory Polysomnography (Psg) System Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Ambulatory Polysomnography (Psg) System Revenue by Country (US$ Million) & (2027-2032) Table 117. Europe Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Ambulatory Polysomnography (Psg) System Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Ambulatory Polysomnography (Psg) System Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Ambulatory Polysomnography (Psg) System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Ambulatory Polysomnography (Psg) System Revenue by Country (2021-2026) & (US$ Million) Table 123. Europe Ambulatory Polysomnography (Psg) System Revenue by Country (US$ Million) & (2027-2032) Table 124. China Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2026) & (US$ Million) Table 125. China Ambulatory Polysomnography (Psg) System Revenue by Type (2027-2032) & (US$ Million) Table 126. China Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2026) & (US$ Million) Table 127. China Ambulatory Polysomnography (Psg) System Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Ambulatory Polysomnography (Psg) System Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2026) & (US$ Million) Table 131. Asia Ambulatory Polysomnography (Psg) System Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Ambulatory Polysomnography (Psg) System Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Ambulatory Polysomnography (Psg) System Revenue by Region (US$ Million) & (2021-2026) Table 134. Asia Ambulatory Polysomnography (Psg) System Revenue by Region (US$ Million) & (2027-2032) Table 135. SAMEA Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2026) & (US$ Million) Table 136. SAMEA Ambulatory Polysomnography (Psg) System Revenue by Type (2027-2032) & (US$ Million) Table 137. SAMEA Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2026) & (US$ Million) Table 138. SAMEA Ambulatory Polysomnography (Psg) System Revenue by Application (2027-2032) & (US$ Million) Table 139. SAMEA Ambulatory Polysomnography (Psg) System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. SAMEA Ambulatory Polysomnography (Psg) System Revenue by Country (2021-2026) & (US$ Million) Table 141. SAMEA Ambulatory Polysomnography (Psg) System Revenue by Country (US$ Million) & (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Ambulatory Polysomnography (Psg) System Image Figure 2. Global Ambulatory Polysomnography (Psg) System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ambulatory Polysomnography (Psg) System Market Size Share 2021 VS 2025 VS 2032 Figure 4. ＜10-Channel Image Figure 5. ≥10-Channel Image Figure 6. Global Ambulatory Polysomnography (Psg) System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ambulatory Polysomnography (Psg) System Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Home Image Figure 10. Others Image Figure 11. Global Ambulatory Polysomnography (Psg) System Market Size (US$ Million) & (2021-2032) Figure 12. Global Ambulatory Polysomnography (Psg) System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Ambulatory Polysomnography (Psg) System Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Ambulatory Polysomnography (Psg) System Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Ambulatory Polysomnography (Psg) System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Ambulatory Polysomnography (Psg) System Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Type (2021-2032) Figure 19. Global Ambulatory Polysomnography (Psg) System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Application (2021-2032) Figure 22. North America Ambulatory Polysomnography (Psg) System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Ambulatory Polysomnography (Psg) System Revenue Share by Type (2021-2032) Figure 24. North America Ambulatory Polysomnography (Psg) System Revenue Share by Application (2021-2032) Figure 25. North America Ambulatory Polysomnography (Psg) System Revenue Share by Country (2021-2032) Figure 26. United States Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Ambulatory Polysomnography (Psg) System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Ambulatory Polysomnography (Psg) System Revenue Share by Type (2021-2032) Figure 31. Europe Ambulatory Polysomnography (Psg) System Revenue Share by Application (2021-2032) Figure 32. Europe Ambulatory Polysomnography (Psg) System Revenue Share by Country (2021-2032) Figure 33. Germany Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Ambulatory Polysomnography (Psg) System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Ambulatory Polysomnography (Psg) System Revenue Share by Type (2021-2032) Figure 43. China Ambulatory Polysomnography (Psg) System Revenue Share by Application (2021-2032) Figure 44. Asia Ambulatory Polysomnography (Psg) System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Ambulatory Polysomnography (Psg) System Revenue Share by Type (2021-2032) Figure 46. Asia Ambulatory Polysomnography (Psg) System Revenue Share by Application (2021-2032) Figure 47. Asia Ambulatory Polysomnography (Psg) System Revenue Share by Region (2021-2032) Figure 48. Japan Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Ambulatory Polysomnography (Psg) System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Ambulatory Polysomnography (Psg) System Revenue Share by Type (2021-2032) Figure 56. SAMEA Ambulatory Polysomnography (Psg) System Revenue Share by Application (2021-2032) Figure 57. SAMEA Ambulatory Polysomnography (Psg) System Revenue Share by Country (2021-2032) Figure 58. Brazil Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Ambulatory Polysomnography (Psg) System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • ＜10-Channel
  • ≥10-Channel
Applications
  • Hospital
  • Home
  • Others
Companies covered
  • Natus Embla
  • Compumedics
  • Neurosoft
  • Cadwell Industries
  • Philips
  • Löwenstein Medical
  • Nihon Kohden
  • Nox Medical
  • Somnomedics AG
  • Advanced Brain Monitoring (ABM)
  • DEYMED Diagnostic
  • Hangzhou NeuroTrace
  • Beijing BMC Medical
  • Hunan VentMed Medical Technology
  • Hangzhou Lucky Day Medical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ambulatory Polysomnography (Psg) System Market by Type
  3. 1.2.1 Global Ambulatory Polysomnography (Psg) System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ＜10-Channel
  5. 1.2.3 ≥10-Channel
  6. 1.3 Ambulatory Polysomnography (Psg) System Market by Application
  7. 1.3.1 Global Ambulatory Polysomnography (Psg) System Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Home
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Ambulatory Polysomnography (Psg) System Market Dynamics
  1. 2.1 Ambulatory Polysomnography (Psg) System Industry Trends
  2. 2.2 Ambulatory Polysomnography (Psg) System Industry Drivers
  3. 2.3 Ambulatory Polysomnography (Psg) System Industry Opportunities and Challenges
  4. 2.4 Ambulatory Polysomnography (Psg) System Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Ambulatory Polysomnography (Psg) System Market Perspective (2021-2032)
  2. 3.2 Global Ambulatory Polysomnography (Psg) System Growth Trends by Region
  3. 3.2.1 Global Ambulatory Polysomnography (Psg) System Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ambulatory Polysomnography (Psg) System Market Size by Region (2021-2026)
  5. 3.2.3 Global Ambulatory Polysomnography (Psg) System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Ambulatory Polysomnography (Psg) System Revenue by Players
  2. 4.1.1 Global Ambulatory Polysomnography (Psg) System Revenue by Players (2021-2026)
  3. 4.1.2 Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Ambulatory Polysomnography (Psg) System Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ambulatory Polysomnography (Psg) System Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Ambulatory Polysomnography (Psg) System Key Players Headquarters & Area Served
  7. 4.4 Global Ambulatory Polysomnography (Psg) System Players, Product Type & Application
  8. 4.5 Global Ambulatory Polysomnography (Psg) System Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Ambulatory Polysomnography (Psg) System Market CR5 and HHI
  11. 4.6.3 2025 Ambulatory Polysomnography (Psg) System Tier 1, Tier 2, and Tier 3
5 Ambulatory Polysomnography (Psg) System Market Size by Type
  1. 5.1 Global Ambulatory Polysomnography (Psg) System Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2032)
  3. 5.3 Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Type (2021-2032)
6 Ambulatory Polysomnography (Psg) System Market Size by Application
  1. 6.1 Global Ambulatory Polysomnography (Psg) System Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2032)
  3. 6.3 Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Natus Embla
  2. 7.1.1 Natus Embla Company Information
  3. 7.1.2 Natus Embla Business Overview
  4. 7.1.3 Natus Embla Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Natus Embla Ambulatory Polysomnography (Psg) System Product Portfolio
  6. 7.1.5 Natus Embla Recent Developments
  7. 7.2 Compumedics
  8. 7.2.1 Compumedics Company Information
  9. 7.2.2 Compumedics Business Overview
  10. 7.2.3 Compumedics Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Compumedics Ambulatory Polysomnography (Psg) System Product Portfolio
  12. 7.2.5 Compumedics Recent Developments
  13. 7.3 Neurosoft
  14. 7.3.1 Neurosoft Company Information
  15. 7.3.2 Neurosoft Business Overview
  16. 7.3.3 Neurosoft Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Neurosoft Ambulatory Polysomnography (Psg) System Product Portfolio
  18. 7.3.5 Neurosoft Recent Developments
  19. 7.4 Cadwell Industries
  20. 7.4.1 Cadwell Industries Company Information
  21. 7.4.2 Cadwell Industries Business Overview
  22. 7.4.3 Cadwell Industries Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Cadwell Industries Ambulatory Polysomnography (Psg) System Product Portfolio
  24. 7.4.5 Cadwell Industries Recent Developments
  25. 7.5 Philips
  26. 7.5.1 Philips Company Information
  27. 7.5.2 Philips Business Overview
  28. 7.5.3 Philips Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Philips Ambulatory Polysomnography (Psg) System Product Portfolio
  30. 7.5.5 Philips Recent Developments
  31. 7.6 Löwenstein Medical
  32. 7.6.1 Löwenstein Medical Company Information
  33. 7.6.2 Löwenstein Medical Business Overview
  34. 7.6.3 Löwenstein Medical Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Löwenstein Medical Ambulatory Polysomnography (Psg) System Product Portfolio
  36. 7.6.5 Löwenstein Medical Recent Developments
  37. 7.7 Nihon Kohden
  38. 7.7.1 Nihon Kohden Company Information
  39. 7.7.2 Nihon Kohden Business Overview
  40. 7.7.3 Nihon Kohden Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Nihon Kohden Ambulatory Polysomnography (Psg) System Product Portfolio
  42. 7.7.5 Nihon Kohden Recent Developments
  43. 7.8 Nox Medical
  44. 7.8.1 Nox Medical Company Information
  45. 7.8.2 Nox Medical Business Overview
  46. 7.8.3 Nox Medical Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Nox Medical Ambulatory Polysomnography (Psg) System Product Portfolio
  48. 7.8.5 Nox Medical Recent Developments
  49. 7.9 Somnomedics AG
  50. 7.9.1 Somnomedics AG Company Information
  51. 7.9.2 Somnomedics AG Business Overview
  52. 7.9.3 Somnomedics AG Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Somnomedics AG Ambulatory Polysomnography (Psg) System Product Portfolio
  54. 7.9.5 Somnomedics AG Recent Developments
  55. 7.10 Advanced Brain Monitoring (ABM)
  56. 7.10.1 Advanced Brain Monitoring (ABM) Company Information
  57. 7.10.2 Advanced Brain Monitoring (ABM) Business Overview
  58. 7.10.3 Advanced Brain Monitoring (ABM) Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Advanced Brain Monitoring (ABM) Ambulatory Polysomnography (Psg) System Product Portfolio
  60. 7.10.5 Advanced Brain Monitoring (ABM) Recent Developments
  61. 7.11 DEYMED Diagnostic
  62. 7.11.1 DEYMED Diagnostic Company Information
  63. 7.11.2 DEYMED Diagnostic Business Overview
  64. 7.11.3 DEYMED Diagnostic Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  65. 7.11.4 DEYMED Diagnostic Ambulatory Polysomnography (Psg) System Product Portfolio
  66. 7.11.5 DEYMED Diagnostic Recent Developments
  67. 7.12 Hangzhou NeuroTrace
  68. 7.12.1 Hangzhou NeuroTrace Company Information
  69. 7.12.2 Hangzhou NeuroTrace Business Overview
  70. 7.12.3 Hangzhou NeuroTrace Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Hangzhou NeuroTrace Ambulatory Polysomnography (Psg) System Product Portfolio
  72. 7.12.5 Hangzhou NeuroTrace Recent Developments
  73. 7.13 Beijing BMC Medical
  74. 7.13.1 Beijing BMC Medical Company Information
  75. 7.13.2 Beijing BMC Medical Business Overview
  76. 7.13.3 Beijing BMC Medical Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Beijing BMC Medical Ambulatory Polysomnography (Psg) System Product Portfolio
  78. 7.13.5 Beijing BMC Medical Recent Developments
  79. 7.14 Hunan VentMed Medical Technology
  80. 7.14.1 Hunan VentMed Medical Technology Company Information
  81. 7.14.2 Hunan VentMed Medical Technology Business Overview
  82. 7.14.3 Hunan VentMed Medical Technology Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Hunan VentMed Medical Technology Ambulatory Polysomnography (Psg) System Product Portfolio
  84. 7.14.5 Hunan VentMed Medical Technology Recent Developments
  85. 7.15 Hangzhou Lucky Day Medical Technology
  86. 7.15.1 Hangzhou Lucky Day Medical Technology Company Information
  87. 7.15.2 Hangzhou Lucky Day Medical Technology Business Overview
  88. 7.15.3 Hangzhou Lucky Day Medical Technology Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Hangzhou Lucky Day Medical Technology Ambulatory Polysomnography (Psg) System Product Portfolio
  90. 7.15.5 Hangzhou Lucky Day Medical Technology Recent Developments
8 North America
  1. 8.1 North America Ambulatory Polysomnography (Psg) System Revenue (2021-2032)
  2. 8.2 North America Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2032)
  3. 8.2.1 North America Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2026)
  4. 8.2.2 North America Ambulatory Polysomnography (Psg) System Revenue by Type (2027-2032)
  5. 8.3 North America Ambulatory Polysomnography (Psg) System Revenue Share by Type (2021-2032)
  6. 8.4 North America Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2032)
  7. 8.4.1 North America Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2026)
  8. 8.4.2 North America Ambulatory Polysomnography (Psg) System Revenue by Application (2027-2032)
  9. 8.5 North America Ambulatory Polysomnography (Psg) System Revenue Share by Application (2021-2032)
  10. 8.6 North America Ambulatory Polysomnography (Psg) System Revenue by Country
  11. 8.6.1 North America Ambulatory Polysomnography (Psg) System Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Ambulatory Polysomnography (Psg) System Revenue by Country (2021-2026)
  13. 8.6.3 North America Ambulatory Polysomnography (Psg) System Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Ambulatory Polysomnography (Psg) System Revenue (2021-2032)
  2. 9.2 Europe Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2032)
  3. 9.2.1 Europe Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2026)
  4. 9.2.2 Europe Ambulatory Polysomnography (Psg) System Revenue by Type (2027-2032)
  5. 9.3 Europe Ambulatory Polysomnography (Psg) System Revenue Share by Type (2021-2032)
  6. 9.4 Europe Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2032)
  7. 9.4.1 Europe Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2026)
  8. 9.4.2 Europe Ambulatory Polysomnography (Psg) System Revenue by Application (2027-2032)
  9. 9.5 Europe Ambulatory Polysomnography (Psg) System Revenue Share by Application (2021-2032)
  10. 9.6 Europe Ambulatory Polysomnography (Psg) System Revenue by Country
  11. 9.6.1 Europe Ambulatory Polysomnography (Psg) System Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Ambulatory Polysomnography (Psg) System Revenue by Country (2021-2026)
  13. 9.6.3 Europe Ambulatory Polysomnography (Psg) System Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Ambulatory Polysomnography (Psg) System Revenue (2021-2032)
  2. 10.2 China Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2032)
  3. 10.2.1 China Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2026)
  4. 10.2.2 China Ambulatory Polysomnography (Psg) System Revenue by Type (2027-2032)
  5. 10.3 China Ambulatory Polysomnography (Psg) System Revenue Share by Type (2021-2032)
  6. 10.4 China Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2032)
  7. 10.4.1 China Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2026)
  8. 10.4.2 China Ambulatory Polysomnography (Psg) System Revenue by Application (2027-2032)
  9. 10.5 China Ambulatory Polysomnography (Psg) System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ambulatory Polysomnography (Psg) System Revenue (2021-2032)
  2. 11.2 Asia Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2032)
  3. 11.2.1 Asia Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2026)
  4. 11.2.2 Asia Ambulatory Polysomnography (Psg) System Revenue by Type (2027-2032)
  5. 11.3 Asia Ambulatory Polysomnography (Psg) System Revenue Share by Type (2021-2032)
  6. 11.4 Asia Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2032)
  7. 11.4.1 Asia Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2026)
  8. 11.4.2 Asia Ambulatory Polysomnography (Psg) System Revenue by Application (2027-2032)
  9. 11.5 Asia Ambulatory Polysomnography (Psg) System Revenue Share by Application (2021-2032)
  10. 11.6 Asia Ambulatory Polysomnography (Psg) System Revenue by Country
  11. 11.6.1 Asia Ambulatory Polysomnography (Psg) System Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Ambulatory Polysomnography (Psg) System Revenue by Country (2021-2026)
  13. 11.6.3 Asia Ambulatory Polysomnography (Psg) System Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ambulatory Polysomnography (Psg) System Revenue (2021-2032)
  2. 12.2 SAMEA Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Ambulatory Polysomnography (Psg) System Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Ambulatory Polysomnography (Psg) System Revenue by Type (2027-2032)
  5. 12.3 SAMEA Ambulatory Polysomnography (Psg) System Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Ambulatory Polysomnography (Psg) System Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Ambulatory Polysomnography (Psg) System Revenue by Application (2027-2032)
  9. 12.5 SAMEA Ambulatory Polysomnography (Psg) System Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Ambulatory Polysomnography (Psg) System Revenue by Country
  11. 12.6.1 SAMEA Ambulatory Polysomnography (Psg) System Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Ambulatory Polysomnography (Psg) System Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Ambulatory Polysomnography (Psg) System Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst